Melanoma Clinical Trial
How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes
The purpose of this research study is to examine the relationship between the microbiota (microscopic organisms) in the gut and the activity of the immune system during skin cancer immunotherapy.
≥18 years of age.
Diagnosis of skin cancer.
Planning to initiate or already on ANY type of immunotherapy.
Able to provide urine and stool specimens.
Major GI surgery in the past 5 years other than cholecystectomy and appendectomy.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.